1. Introduction {#sec1}
===============

Mastitis is a common disease for mammals all over the world that occurs frequently around parturition ([@bib39]). Previous studies showed the average prevalence of mastitis in sows was about 13% ([@bib13]) while it was about 25.5% in lactating heifers in Dutch ([@bib26]). Piglet mortality around one week in the litters of coliform mastitis-affected sows varies from 5.0% to 38.6% ([@bib13]). Cows often have mastitis without obvious clinical symptoms named subclinical mastitis ([@bib15]). Subclinical mastitis results in leakage of plasma constituents into milk and causes gut damage of infants. Antibiotics are often used to deal with mastitis while overuse of antibiotics may lower the quality and safety of animal products and thus threaten the health of humans ([@bib17], [@bib27]).

Up to date, we know little about how to effectively prevent mastitis, and there is little knowledge about the underlying mechanism. Although *Escherichia coli* has been proposed to play critical roles in triggering mastitis through the toll-like receptor (TLR) pathway ([@bib24]) and infusion of lipopolysaccharide (LPS) has been proved to potentially stimulate expression of proinflammatory cytokines ([@bib12]), why mammary glands are more susceptible around parturition ([@bib3]) remains to be elucidated. In humans, increased concentration of non-esterified fatty acid (NEFA) can stimulate systemic immune response and is linked to inflammatory-based diseases ([@bib32]). Notably, increased lipolysis takes place around parturition and thus results in large increases in NEFA concentration ([@bib7]). In addition, enhanced lipolytic activity around parturition also results in break down of fat depots and rapid changes of plasma fatty acid composition ([@bib1]). It was reported that saturated fatty acids (SFA) concentration in plasma of women at parturition was greater than that at week 24 of gestation ([@bib30]). Saturated fatty acids were convinced to be capable of stimulating TLR-mediated proinflammatory signaling pathways ([@bib18]). Moreover, our previous study indicated that consumption of fish oil could attenuate mammary inflammation which might be linked to reduced plasma concentration of SFA ([@bib20]). These results suggested that increased fatty acids metabolism around parturition may play roles in regulation of inflammatory responses in mammary glands. Therefore, detecting the variation in fatty acid composition of mammals across the reproductive cycle may be helpful for understanding why mammary inflammation occurs frequently around parturition.

On the other hand, it is well documented in cows ([@bib4]) and sows ([@bib2], [@bib33]) that oxidative stress occurs at late gestation and early lactation due to severe catabolic status. And oxidative stress was known to be strongly linked to production of proinflammatory cytokines ([@bib10]; [@bib34]; [@bib35], [@bib36]), which has been known to be key factors in inducing mastitis ([@bib23]). In consequence, enhanced oxidative stress around parturition may affect the expression of proinflammatory cytokines in mammary gland. However, the variation of the proinflammatory cytokines across the reproductive cycle in mammary gland of mammals is poorly understood.

In the present study, the pregnant and age-matched non-pregnant rats were used as models to evaluate changes in plasma fatty acids profile and mammary proinflammatory cytokines expression in different time point of a reproductive cycle, which may further our understanding about the high incidence of mammary inflammation around parturition.

2. Materials and methods {#sec2}
========================

2.1. Animals and facilities {#sec2.1}
---------------------------

All procedures outlined in this study were approved by the Animal Care and Use Committee of the Animal Nutrition Institute, Sichuan Agricultural University. All experiments involved animals were conducted in conformity with the Public Health Service Policy on Humane Care and Use of Laboratory Animals. The experimental rats (Virgin female Sprague-Dawley rats) were purchased from Sichuan Academy of Medical Sciences-Sichuan Provincial People\'s Hospital Experimental Animal Research Institute (Sichuan, China), and housed in galvanized-steel cages with bedding and maintained at a controlled temperature (22 ± 2°C) and relative humidity (60 ± 10%) with a 12-h light/dark cycle.

2.2. Diets and treatments {#sec2.2}
-------------------------

The experimental diet ([Table 1](#tbl1){ref-type="table"}) was formulated to meet or exceed the nutrient requirements of gestating and lactating rats as recommended by AIN-93G. To set a proposed level of dietary SFA and n-3 polyunsaturated fatty acid (PUFA), the 7 kg fat included in the experimental diet was composed of 5 kg lard and 2 kg soybean oil. The fatty acid (FA) composition of the diet is showed in [Table 2](#tbl2){ref-type="table"}. The diet was stored at −20°C to avoid PUFA oxidation during the experimental period. A total of 47 rats were included in the experiment. When rats grew to sexual maturity, 1 female rat (231 ± 5 g) per cage was housed together with 1 male rat (weighing 300 to 330 g) in the same cage to complete mating. The females were examined each morning for the presence of a seminal plug in the vagina. The day detecting a plug was designated embryonic day 1 of gestation and plug-positive females were considered 'pregnant'. Immediately after the first observation of a plug, the female rats were removed and housed individually, and began to receive the experimental diet. At the same time, age- and body weight-matched virgin rats also began to receive the experimental diet. All rats had free access to water at all times. Mammary tissue samples were obtained at days 1 and 14 of gestation as well as day 3 postpartum, respectively. All blood samples were obtained (about 3 mL) through intra-orbital bleeding (for rats to be slaughtered thereafter) or by tail-cutting (for virgin rats that continued to be reared) and collected in duplicate in heparinized tubes. The samples were then centrifuged at 1500 × *g* for 15 min at 4°C. All blood samples were obtained after a 12-h fast and stored at −20°C until analysis. Immediately after anesthesia, the mammary tissue samples for detection of mRNA abundance were collected, snap frozen in liquid nitrogen and stored at −80°C. The mammary tissue samples for histopathologic examination and immunohistochemistry detection were fixed in 4% paraformaldehyde and stored at 4°C until analysis.Table 1Ingredients and composition of the experimental diet (air-dry basis).IngredientContent, %CompositionContent, %Corn starch39.75Crude protein16.23Casein20ME, Mcal/kg3.81Gelatinization starch13.2Lysine1.53Sucrose10Methionine0.57Fat[1](#tbl1fn1){ref-type="table-fn"}7Calcium0.50Fiber5Available phosphorus0.16Mineral premix[2](#tbl1fn2){ref-type="table-fn"}3.5Vitamin premix[3](#tbl1fn3){ref-type="table-fn"}1L-cysteine0.3Choline Chloride0.25Total100[^2][^3][^4]Table 2Fatty acid composition of the lard (g/100 g) and the diet (g/kg) (as fed basis).Fatty acid[1](#tbl2fn1){ref-type="table-fn"}LardLard dietC14:01.250.42C16:026.149.91C18:019.897.20C20:00.340.17C16:11.480.52C18:137.6215.70C20:10.910.40C22:1ND0.17C18:2n610.2010.05C18:3n30.980.96C20:5n3ND0.087C22:6n3NDNDOther1.190.41∑FA10046∑SFA47.6217.70∑MUFA40.0116.80∑PUFA11.1811.09∑SFA/∑FA47.6238.48∑MUFA/∑FA40.0136.52∑PUFA/∑FA11.1824.11∑n-30.981.04∑n-610.210.05∑n-6/∑n-310.419.62[^5][^6]

2.3. ELISA analysis {#sec2.3}
-------------------

Non-esterified fatty acids concentration was determined in duplicate by commercial ELISA kits (GBD, San Diego, CA, USA) as described by the manufacturer\'s protocol. About 100 μL of standard, blank, and sample was added to the wells of the assay plate, respectively, and the assay plate was covered with the adhesive strip. After incubation for 2 h at 37°C, the liquid of each well was removed without washing. Then, 100 μL of Biotin-antibody working solution was added to each well. After incubation for 1 h at 37°C, liquid in the wells was aspirated, and 200 mL of wash buffer was used to wash the wells, guaranteeing that liquid was removed completely in each step. Next, 100 μL of HRP-avidin working solution was added to each well, and a new adhesive strip was used to cover the plate, allowing incubation for 1 h at 37°C. Afterward, the wells were washed as described above. This was followed by adding 90 μL of Trimethyl boron substrate to each well with incubation for 30 min at 37°C. Keep the plate away from drafts and other temperature fluctuations in the dark. At last, 50 μL of stop solution was added to each well and the reaction was thus halted. The optical density of each well was determined within 30 min using a microplate reader set at 450 nm. A standard curve was created and the corresponding NEFA concentrations were determined according to the standard curve.

The plasma meloperoxidase (MPO) activity was determined using a spectrophotometric method. The MPO activity was calculated with the absorbance (at 460 nm) changes causing by reducing H~2~O~2~ with the presence of o-dianisidine. All reagents were included in a commercial MPO kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).

2.4. FA composition analysis {#sec2.4}
----------------------------

Plasma FA composition were analyzed according to previous research ([@bib11]) with modification. Briefly, 30 to 50 mg plasma sample was weighed in glass tubes. About 4 mL acetyl chloride and methanol solution (1:10, volume) was added slowly. After transesterification, the pooled solvent extracts were dried under a gentle stream of nitrogen at room temperature. Residues were dissolved in 5 mL hexane with internal standard. After water bath at 80°C for 2 h, 5 mL 7% potassium carbonate was added, vibrating until uniform, standing for stratification and collecting supernatant. Analysis was performed on a Hewlett-Packard 6890 gas chromatograph equipped with a flame ionization detector. The column temperature was held at 180°C for 10 min and in a stepwise fashion reached a plateau of 230°C. The detector temperature was 270°C. Helium was used as carrier gas.

2.5. RNA analysis {#sec2.5}
-----------------

RNA analysis was performed as we described previously ([@bib20]). Briefly, total RNA was extracted using a TRIzol reagent kit (Invitrogen, Carlsbad, CA, USA). The cDNA was prepared using a reverse transcription (RT) kit (TAKARA, Dalian, China) following the manufacture\'s instruction. Primers were synthesized by Chengdu Tiantai Biological Company (Chengdu, China). β-actin was used as an internal control according to the work of [@bib14]. The nucleotide primer sequences are listed in [Table 3](#tbl3){ref-type="table"}. Quantitative real-time RT-PCR analysis was performed using a 7900 real-time PCR system (Applied Biosystems, Foster City, CA, USA) and SYBR Green assays (Master Mix SYBR Green TAKARA, Dalian, China). The specificity of PCR products were examined with melting curve analysis. Results (fold changes) were expressed as 2^−ΔΔCt^ with ΔΔCt = (Ct *ij* − Ct β-actin *j*) − (Ct *i*1 − Ct β-actin1), where Ct *ij* and Ct β-actin *j* are the Ct for gene *i* and for β-actin in a sample (named *j*), and where Ct *i*1 and Ct β-actin1 are the Ct in sample 1, expressed as the standard.Table 3Primer sequences used to amplify rat cytokines.GenePrimer sequences (5′ to 3′)Product size, bpGenBank accession No.*IL-1β*ForwardTGACCTGTTCTTTGAGGCTGAC113[M98820.1](ncbi-n:M98820.1){#intref0010}ReverseCGAGATGCTGCTGTGAGATTTG*TNF-α*ForwardCCACTCTGACCCCTTTACTCTGA154[NM_013693.2](ncbi-n:NM_013693.2){#intref0015}ReverseCTGTCCCAGCATCTTGTGTTTC*IL-8*ForwardCCAGCAGGAAACCAGAAGAAAG123[NM_001173399.2](ncbi-n:NM_001173399.2){#intref0020}ReverseCAACTTTGTCACGACCATACCC*XOR*ForwardGATTCTCACACACCTCCTGACG156[NM_011723.2](ncbi-n:NM_011723.2){#intref0025}ReverseCCCCACACACACACACACACTATβ-actinForwardCTGTGTGGATTGGTGGCTCTATC133[NM_031144.2](ncbi-n:NM_031144.2){#intref0030}ReverseGCTCAGTAACAGTCCGCCTAGAA[^7]

2.6. Histopathologic examination {#sec2.6}
--------------------------------

Tissue specimens were fixed in 4% paraformaldehyde for 24 h. Standard dehydration and paraffin-wax embedding procedures were used to produce tissue blocks. Hematoxylin and eosin stained slides were prepared using standard methods. The prevalence of the polymorphonuclear neutrophils (PMN) in alveoli was estimated by light microscopic (Olympus BH2, Tokyo, Japan) analyses at a magnification of 400× as previously described ([@bib21]). Briefly, 4 sections of the rat mammary tissue samples were quantified for each animal. Ten fields were selected randomly per sample. Results are presented as average PMN infiltration scores for each time point.

2.7. Immunohistochemistry {#sec2.7}
-------------------------

Polyclonal antibodies combined with the avidin-biotinperoxidase complex technique were used for the immunohistochemical detection of interleukin-1β (IL-1β) (Abnova, Walnut, CA, USA) and tumor necrosis factor-α (TNF-α) (Novus, SaintCharles, MO, USA). All samples from 1 animal were analyzed within the same assay run, and within each assay run treatment animals to be compared were included. The quantification of IL-1β and TNF-α protein expression level in mammary tissue samples was performed as previously described ([@bib37]). For each sample, a relative value of the amount of cytokine produced was expressed as the average percentage of the positively stained areas in 10 (for IL-1β) or 5 (for TNF-α) randomly selected view fields.

2.8. Statistical analysis {#sec2.8}
-------------------------

Data were analyzed using the General Linear Model procedures of SAS statistical package (V8.1, SAS Institute Inc., Cary, NC). Least-squares means comparison was used to evaluate differences among treatments. *P*-value ≤0.05 were considered statistical significance. Values were presented as means ± SE.

3. Results {#sec3}
==========

3.1. Plasma NEFA concentration and FA profile at different reproductive stages {#sec3.1}
------------------------------------------------------------------------------

As shown in [Fig. 1](#fig1){ref-type="fig"}, plasma NEFA concentration in non-pregnant rats was not changed (*P* \> 0.05) with the advance of time. It was also not different (*P* \> 0.05) between the value of the pregnant rats at day 1 and those at day 14 of gestation. However, a significant (*P* \< 0.05) increase in plasma NEFA concentration was observed at day 3 postpartum compared with that at day 14 of gestation. The concentration of several FA greatly changed, especially the PUFA ([Table 4](#tbl4){ref-type="table"}). At day 3 postpartum, plasma arachidonic acid (ARA), docosahexaenoic acid (DHA) and total n-3 PUFA concentrations were significantly (*P* \< 0.05) greater than those at day 14 of gestation. Notably, ARA:eicosapentaenoic acid (EPA) ratio at day 3 postpartum was higher than that at day 1 and day 14 of gestation.Fig. 1Plasma non-esterified fatty acids (NEFA) concentration (μg/mL) of the rats at different reproductive stages. Blood samples were collected at day 1 of gestation from non-pregnant rats (*n* = 5) and pregnant rats (*n* = 13), day 14 of gestation from non-pregnant rats (*n* = 6) and pregnant rats (*n* = 12) and day 3 postpartum from non-pregnant rats (*n* = 6) and pregnant rats (*n* = 5) and determined using ELISA kits. Values are presented as means ± SE. Different letters signify statistical difference (*P* \< 0.05).Table 4Plasma fatty acid concentration (μg/mL) of the rats at different reproductive stages.Fatty acidDay 1 of gestationDay 14 of gestationDay 3 postpartumMeanSEMeanSEMeanSEC18:3n310.321.1612.421.599.031.10C20:5n36.280.936.160.594.970.72C22:6n365.09^ab^6.1945.71^b^1.9591.36^a^15.86C20:4n6309.89^ab^50.52248.16^b^13.24406.70^a^52.01ARA:EPA50.61^b^7.8042.06^b^2.3184.31^a^7.22n-3 PUFA81.69^ab^6.1165.42^b^3.87106.47^a^16.37SFA1542.50150.961230.73178.831431.02145.23Total FA2577.71192.642209.09183.432632.85286.82[^8][^9]

3.2. Mammary inflammation mediators at different reproductive stages {#sec3.2}
--------------------------------------------------------------------

Real time-PCR results indicated that the mRNA abundance of *IL-1β*, *TNF-α*, *IL-8* and *XOR* in mammary of the pregnant rats at day 14 of gestation was greater (*P* \< 0.05) than that of age-matched non-pregnant rats ([Fig. 2](#fig2){ref-type="fig"}). Immunohistochemistry analysis revealed that the protein levels of IL-1β and TNF-α were greater at day 3 postpartum than those at day 1 of gestation. In addition, the protein level of IL-1β at day 3 postpartum was higher than that at day 14 of gestation ([Fig. 3](#fig3){ref-type="fig"}). Moreover, MPO activity ([Fig. 4](#fig4){ref-type="fig"}) and PMN prevalence ([Fig. 5](#fig5){ref-type="fig"}) were greater (*P* \< 0.05) at day 3 postpartum than those at day 1 of gestation. Meloperoxidase activity at day 3 postpartum was also greater (*P* \< 0.05) than that at day 14 of gestation.Fig. 2The mRNA abundance of interleukin-1β *(IL-1β*), tumor necrosis factor-α *(TNF-α*), *IL-8* and xanthine oxidoreductase (*XOR*) in udder of rats. The mRNA abundances of *IL-1β*, *TNF-α*, *IL-8* and *XOR* were determined by RT-PCR with mammary tissues obtained after saline infusion at day 14 of gestation from pregnant rats (*n* = 7) and age-matched non-pregnant rats (*n* = 11). Values are presented as means ± SE. Differences between pregnant and non-pregnant rats were indicated by asterisks (\*\*\*\**P* \< 0.0001, \*\*\**P* \< 0.001, \*\**P* \< 0.01 and \**P* \< 0.05).Fig. 3Immunohistochemical localization of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in mammary glands of the rats at different reproductive stages. Mammary glands were collected after saline infusion from non-pregnant rats that designated as rats at day 1 of gestation (*n* = 6), pregnant rats that was infused by saline at day 14 of gestation (*n* = 5) and day 3 postpartum (*n* = 5). (A) Interleukin-1β and TNF-α production is presented as the average percentage of the positively stained areas. The microphotograph from one rat with the positive primary IL-1β or TNF-α antibody was visualized with diaminobenzidine reaction. The area positive for (B) IL-1β and (C) TNF-α in mammary tissue of rats at different reproductive stages was quantified by Easy Image 3000 software at a magnification of 400×. Values are presented as means ± SE. Different letters signify statistical difference (*P* \< 0.05) within the same protein.Fig. 4Plasma meloperoxidase (MPO) activity (IU/L) at different reproductive stages. Meloperoxidase activity was determined using a spectrophotometric method with blood samples collected from the rats infused by saline at day 1 of gestation (*n* = 6), day 14 of gestation (*n* = 6) and day 3 postpartum (*n* = 6). Values are presented as means ± SE. Different letters signify statistical difference (*P* \< 0.05).Fig. 5Histopathology of mammary glands of rats at different reproductive stages. (A) Hematoxylin and eosin stained slides were made with mammary tissues collected from non-pregnant rats that designated as rats at day 1 of gestation (*n* = 6), pregnant rats at day 14 of gestation (*n* = 5) and day 3 postpartum (*n* = 5). (B) Polymorphonuclear neutrophils prevalence in alveoli was estimated by using light microscopic (Olympus BH2, Toyko, Japan) analysis at a magnification of 400×. Values are presented as means ± SE. Different letters signify statistical difference (*P* \< 0.05).

4. Discussion {#sec4}
=============

In the present study, the plasma FA profile and mammary inflammation indicators at different reproductive stages were determined to explain the high incidence of mastitis around parturition. Across the reproductive cycle, great changes took place in plasma FA profiles. From day 14 of gestation to day 3 postpartum, the increased plasma concentration of DHA resulted in elevation of n-3 PUFA. The elevated DHA here could be ascribed to increased NEFA concentration in plasma ([@bib29]). At day 3 postpartum, NEFA concentration increased significantly compared with that at days 1 and 14 of gestation which was in line with a previous study ([@bib5]). Increased plasma concentration of NEFA might indicate the reduction in the body content of adipose tissue which could lead to impaired immune cell function ([@bib22]) and increased susceptibility to exogenous pathogens. Moreover, the predominant FA in plasma NEFA was shown to be palmitic and stearic acids, both of which were known to be capable of enhancing the production of inflammatory cytokines. For example, palmitic acid can enhance the production of cytokines TNF-α, IL-1β and IL-8 in monocytes through its activated molecule palmitoyl-CoA ([@bib5]). Moreover, stearate and palmitate can induce the expression of cyclooxygenase 2, an inflammatory eicosanoid enzyme ([@bib19]). Notably, ARA:EPA ratio at day 3 postpartum increased to twice that at day 14 of gestation and was significantly higher than that at day 1 of gestation. Plasma concentration of ARA at day 3 postpartum was also higher than that at day 14 of gestation. It was demonstrated that increased production of ARA could cause inflammation by triggering proinflammatory eicosanoid generation ([@bib16]), which was attributable to oxygenation of ARA ([@bib6]). As mentioned above, parturition is accompanied by extensive oxidative stress and may thus facilitate oxygenation of ARA. Previous studies also showed that the decreased production of IL-1 and TNF was accompanied by a decreased ARA:EPA ratio in the membrane phospholipids of mononuclear cells, indicating the significant role of ARA in proinflammatory responses ([@bib8]). In turn, the increased ARA:EPA ratio with the advance of gestation might be accompanied by higher production of IL-1 and TNF.

Consequently, proinflammatory cytokines in mammary glands across the reproductive cycle were determined. An important finding was that with the advance of pregnancy, there was up-regulated mRNA expression of proinflammatory cytokines in mammary glands including *IL-1β*, *TNF-α* and *IL-8*, the mRNA abundance of which was significantly greater in pregnant rats at day 14 of gestation than that in the match-up non-pregnant rats. Moreover, immunohistochemistry analysis revealed that the protein expression level of TNF-α was greater at day 14 of gestation and day 3 postpartum than that at day 1 of gestation and the protein expression level of IL-1β was the greatest at day 3 postpartum among the three time points evaluated. Previous study showed that there was a significant increase in IL-1β, TNF-α and IL-8 at both mRNA levels ([@bib38]) and protein levels ([@bib37]) in the inoculated mammary glands of sows that developed clinical signs of mastitis. It was therefore inferred that proinflammatory cytokines in mammary glands, linked closely with mastitis, tended to increase with the advance of gestation and lactation. Those inflammatory cytokines were known to play critical roles in neutrophils recruitment into the mammary glands ([@bib23]). In the present study, plasma MPO activity and PMN prevalence in mammary glands were observed to reach a peak at day 3 postpartum. Meloperoxidase activity was known as a marker reflecting the function of neutrophil ([@bib25]). Polymorphonuclear neutrophils prevalence has been proved to be a principal marker of mastitis after intramammary infection with *E. coli* ([@bib28]). The aggravated PMN prevalence in the mammary glands might be induced by the over expression of *IL-1β* and *TNF-α*, both of which were documented as key mediators that participate in neutrophil recruitment to the mammary glands. Moreover, neutrophils recruited to the site of infection would phagocytize bacteria and produce reactive oxygen species, low molecular weight antibacterial peptides, and defensins, which eliminate a wide variety of pathogens that cause mastitis ([@bib23]).

Another important finding was that the mRNA abundance of *XOR* was also greater in pregnant rats at day 14 of gestation than that in the match-up non-pregnant rats. Previous studies have shown that increased *XOR* expression contributed to increased synthesis of numerous ROS ([@bib31]), which may facilitate activation of TLR4 signaling pathway ([@bib9]). Toll-like receptor 4 is a member of pattern-recognition receptors that play critical roles in the innate immune system in response to microbial pathogens. The high activity of TLR4 may enhance the innate immune responses of the organisms. Therefore, with the advance of gestation, TLR4 in mammary gland cells can be activated more easily in response to exogenous pathogens owing to enhanced expression of XOR. Activation of TLR4 may further promote the production of proinflammatory cytokines and recruitment of neutrophils to mammary glands.

5. Conclusion {#sec5}
=============

In conclusion, our results indicate that expression of proinflammatory cytokines and *XOR* as well as plasma NEFA and ARA:EPA ratio were all increased with the advance of gestation. Increased plasma NEFA and ARA:EPA ratio as well as the mRNA expression level of *XOR* could enhance the production of proinflammatory cytokines, which would facilitate the neutrophil recruitment to mammary glands. Therefore, in late gestation and early lactation, the mammary glands are in a vulnerable status. Once invaded by pathogens, inflammatory responses may be stimulated. These results may be helpful for understanding the high incidence of mastitis around parturition.
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[^2]: The 7 kg fat was composed of 5 kg lard and 2 kg soybean oil in the lard diet.

[^3]: Provided per kg of diet: calcium 5000 mg, phosphorus 1561 mg, potassium 3600 mg, sodium 1019 mg, chlorine 1517 mg, magnesium 510 mg, iron 35 mg, zinc 30 mg, manganese 10 mg, copper 6 mg, selenium 0.15 mg, iodine 0.2 mg.

[^4]: Provided per kg of diet: vitamin A 4000 IU, vitamin D~3~ 1000 IU, vitamin K~3~ 0.75 mg, vitamin B~1~ 6.0 mg, vitamin B~2~ 7.0 mg, vitamin B~6~ 6.0 mg, vitamin B~12~ 0.02 mg, nicotinic acid 30.0 mg, D-calcium pantothenate 15.3 mg, folic acid 2.0 mg, biotin 0.2 mg.

[^5]: ND = not detected; FA = fatty acids; SFA = saturated fatty acids; MUFA = monounsaturated fatty acid; PUFA = polyunsaturated fatty acid.

[^6]: ∑FA means the sum of content of all fatty acids evaluated; ∑SFA means the sum of C14:0, C16:0, C18:0 and C20:0 content; ∑MUFA means the sum of C16:1, C18:1, C20:1 and C22:1 content; ∑PUFA means the sum of C18:2n6, C18:3n3, C20:5n3 and C22:6n3 content; ∑n-3 means the sum of C18:3n3, C20:5n3 and C22:6n3 content; ∑n-6 means the content of C18:2n6.

[^7]: *IL-1β* = interleukin-1β; *TNF-α* = tumor necrosis factor-α; *IL-8* = interleukin-8; *XOR* = xanthine oxidoreductase.

[^8]: ARA = arachidonic acid; EPA = eicosapntemacnioc acid; PUFA = polyunsaturated fatty acids; SFA = saturated fatty acids; FA = fatty acids; SE = standard error.

[^9]: ^a,b^ Mean values within a row without a common superscript differ (*P* \< 0.05).
